• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Gastroenterology

Patient-controlled pain meds superior to epidural after laparoscopic surgery

bySayed ImtiazandChaz Carrier
August 20, 2014
in Gastroenterology, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. When compared to epidural pain control, patient controlled analgesia was associated with better outcomes and pain control in laparoscopic colorectal surgery patients.

2. Epidural analgesia slowed recovery without providing any additional benefit. 

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Pain control is one of the cornerstones of post-operative patient care. Evidence is mixed about the use of epidural devices for pain control in laparoscopic colorectal surgery patients. This study analyzed 128 patients who were randomized to either epidural analgesia (EDA) or patient controlled analgesia (PCA) and followed with an endpoint of medical recovery which was defined as: sufficient oral pain control, fully mobilized or comparable to pre-operative status, and tolerating oral intake requirements 2/3 of normal meal. PCA was associated with fewer complications, shorter hospital stays, less perioperative use of vasopressors, and no difference in pain scores post-operatively.

Strengths of this study included randomization, clearly defined endpoints and the use of intention-to-treat analysis to reduce bias. Weaknesses include the lack of power in the study with an initial goal of reaching statistical significance if >64 patients were enrolled in each arm of the study and on 57 patients were analyzed with PCA. Also the use of an enhanced recovery pathway itself may be a confounding variable that affected the outcome of EDA or PCA use because other perioperative pathways may have negated the benefit of PCA use.

Click to read the study in the Annals of Surgery

Relevant Reading: Cost-effectiveness of the implementation of an enhanced recovery protocol for colorectal surgery

RELATED REPORTS

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

Pembrolizumab did not show overall survival benefit in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer

Addition of atezolizumab to capecitabine + bevacizumab is not clinically beneficial in the treatment of refractory metastatic colorectal cancer

In-Depth [randomized controlled trial]: Of the 266 patients initially evaluated, 128 met inclusion criteria and were randomized to either EDA or PCA. The 65 EDA patients and 57 PCA patients had similar baseline health status and demographics. Post-operative length of stay showed similar interquartile ranges of 3-7.5 for EDA and 3-6 for PCA (p=.082). Complications were significantly higher in the EDA group (54% vs 33%; p=.029). Vasopressor treatment at pre-op, day of operation and post-op day 1 were all significantly higher in the EDA group (90% vs 74%, P = 0.018, 27% vs 4%, P < 0.001, and 29% vs 4%, P < 0.001 respectively). The goal qualitative pain score was <4/10  and was assessed twice a day. EDA and PCA were discontinued according to the study protocol on POD 2 in 47 (72%) and 55 (96%) of patients, respectively (P = 0.005). Treatment time was significantly longer in the EDA group (2.33 ± 1.17 days vs 1.65 ± 0.66 days, P < 0.001). Other complications included 17% foley catheter re-insertion in the EDA group vs 11% in PCA group as well as 3 re-admissions from the EDA group versus no re-admissions in the PCA group. In summary, while length of stay may be similar, medical recovery and complication rates including vasopressor requirements are decreased using PCA in laparoscopic colorectal surgery in an enhanced recovery pathway.

More from this author: Prospective randomized study of monopolar scissors, bipolar vessel sealer and ultrasonic shears in laparoscopic colorectal surgery

Image: PD 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: colorectal cancerlaparoscopypain management
Previous Post

Oxygen readings sway decision to hospitalize infants with bronchiolitis

Next Post

Exome sequencing potentially valuable in diagnosing familial cerebellar ataxias

RelatedReports

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia
StudyGraphics

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

May 4, 2022
Oophorectomy associated with reduced cancer risk and all-cause mortality for BRCA1/2 patients
Oncology

Pembrolizumab did not show overall survival benefit in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer

April 18, 2022
Noninvasive imaging method detects and evaluates size of metastases
Chronic Disease

Addition of atezolizumab to capecitabine + bevacizumab is not clinically beneficial in the treatment of refractory metastatic colorectal cancer

February 25, 2022
Normal renal ultrasound only rules out high grade vesicoureteral reflux in infants
Gastroenterology

Higher abundance of dietary sulfur-reducing microbes was associated with increased risk of colorectal cancer

January 4, 2022
Next Post
BRAF V600E mutations linked with increased mortality in thyroid cancer

Exome sequencing potentially valuable in diagnosing familial cerebellar ataxias

Stem cell transplant may be effective in sickle cell disease

Transfusion therapy linked with reduced neurovascular disease in sickle cell anemia

On-demand inhalation treatment for bronchiolitis is superior to fixed schedule treatment

Clarithromycin linked with increased risk of cardiac death

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.